45337CAM4
Incyte Corporation
Could not find a ticker for this position, may be a filing error
A biopharmaceutical company that develops treatments for blood cancers and other cancers (JAKAFI, ICLUSIG), plus creams for skin conditions like vitiligo and eczema (OPZELURA). Founded in 1991 in Palo Alto, it began as a genomics pioneer selling its LifeSeq gene database to researchers before pivoting to making its own drugs. Its name blends "insight" with "cyt," the Greek root for cell — a nod to its genome-sequencing roots.
CONVERTIBLEUnderlying: INCYCUSIP: 45337CAM4HealthcareUS1 derivative reporter
0.375% Convertible Senior Notes due 2018
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
